Caridad Martinez

5.9k total citations · 1 hit paper
54 papers, 2.8k citations indexed

About

Caridad Martinez is a scholar working on Hematology, Oncology and Epidemiology. According to data from OpenAlex, Caridad Martinez has authored 54 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Hematology, 24 papers in Oncology and 21 papers in Epidemiology. Recurrent topics in Caridad Martinez's work include Hematopoietic Stem Cell Transplantation (21 papers), Cytomegalovirus and herpesvirus research (17 papers) and Virus-based gene therapy research (11 papers). Caridad Martinez is often cited by papers focused on Hematopoietic Stem Cell Transplantation (21 papers), Cytomegalovirus and herpesvirus research (17 papers) and Virus-based gene therapy research (11 papers). Caridad Martinez collaborates with scholars based in United States, Italy and Spain. Caridad Martinez's co-authors include Robert A. Krance, Helen E. Heslop, Cliona M. Rooney, Malcolm K. Brenner, Adrian P. Gee, Hao Liu, Bambi Grilley, Gianpietro Dotti, Barbara Savoldo and April Durett and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Caridad Martinez

51 papers receiving 2.8k citations

Hit Papers

Inducible Apoptosis as a Safety Switch for Adoptive Cell ... 2011 2026 2016 2021 2011 250 500 750 1000

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Caridad Martinez United States 16 1.7k 926 870 748 568 54 2.8k
Carolina Colli Cruz United States 26 2.1k 1.2× 1.4k 1.5× 863 1.0× 810 1.1× 603 1.1× 93 3.3k
Marie Bleakley United States 27 2.0k 1.2× 1.5k 1.7× 690 0.8× 612 0.8× 423 0.7× 55 3.4k
Gary D. Myers United States 13 2.2k 1.3× 1.1k 1.2× 1.1k 1.2× 618 0.8× 621 1.1× 20 2.9k
Brigitte Sénéchal United States 18 2.3k 1.3× 1.6k 1.7× 631 0.7× 813 1.1× 436 0.8× 43 4.0k
Bianca Santomasso United States 19 3.2k 1.8× 764 0.8× 683 0.8× 779 1.0× 402 0.7× 46 3.7k
Alana A. Kennedy‐Nasser United States 13 1.3k 0.8× 757 0.8× 669 0.8× 517 0.7× 396 0.7× 23 2.1k
Daniel J. Landsburg United States 23 2.4k 1.4× 721 0.8× 716 0.8× 722 1.0× 376 0.7× 136 3.3k
Meng-Fen Wu United States 24 1.9k 1.1× 642 0.7× 537 0.6× 679 0.9× 383 0.7× 43 2.6k
Patrick J. Hanley United States 27 1.2k 0.7× 816 0.9× 524 0.6× 362 0.5× 842 1.5× 119 2.3k
Sarah Nikiforow United States 31 1.8k 1.0× 1.4k 1.5× 310 0.4× 463 0.6× 509 0.9× 152 3.4k

Countries citing papers authored by Caridad Martinez

Since Specialization
Citations

This map shows the geographic impact of Caridad Martinez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Caridad Martinez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Caridad Martinez more than expected).

Fields of papers citing papers by Caridad Martinez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Caridad Martinez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Caridad Martinez. The network helps show where Caridad Martinez may publish in the future.

Co-authorship network of co-authors of Caridad Martinez

This figure shows the co-authorship network connecting the top 25 collaborators of Caridad Martinez. A scholar is included among the top collaborators of Caridad Martinez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Caridad Martinez. Caridad Martinez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pfeiffer, Thomas, Ifigeneia Tzannou, Meng-Fen Wu, et al.. (2023). Posoleucel, an Allogeneic, Off-the-Shelf Multivirus-Specific T-Cell Therapy, for the Treatment of Refractory Viral Infections in the Post-HCT Setting. Clinical Cancer Research. 29(2). 324–330. 49 indexed citations
2.
Wu, Meng-Fen, Tao Wang, Erin Doherty, et al.. (2023). Blinatumomab Therapy Is Associated with Favorable Outcomes after Allogeneic Hematopoietic Cell Transplantation in Pediatric Patients with B Cell Acute Lymphoblastic Leukemia. Transplantation and Cellular Therapy. 30(2). 217–227. 4 indexed citations
3.
Friend, Brian D., Ibrahim N. Muhsen, Shreeya Patel, et al.. (2022). Rituximab as adjunctive therapy to BEAM conditioning for autologous stem cell transplantation in Hodgkin lymphoma. Bone Marrow Transplantation. 57(4). 579–585. 1 indexed citations
4.
Agarwal, Shreya, Nahir Cortes‐Santiago, Michael E. Scheurer, et al.. (2022). Diffuse alveolar hemorrhage: An underreported complication of transplant associated thrombotic microangiopathy. Bone Marrow Transplantation. 57(6). 889–895. 10 indexed citations
5.
Fishman, Douglas S., et al.. (2021). Gastric Adenocarcinoma in the Setting of IPEX Syndrome. SHILAP Revista de lepidopterología. 2021. 1–4. 3 indexed citations
6.
Dahlberg, Ann, Joanne Kurtzberg, Jaap Jan Boelens, et al.. (2021). Guidelines for Pediatric Unrelated Cord Blood Transplantation—Unique Considerations. Transplantation and Cellular Therapy. 27(12). 968–972. 5 indexed citations
7.
Naik, Swati, Olive S. Eckstein, Ghadir Sasa, et al.. (2020). Incorporation of thiotepa in a reduced intensity conditioning regimen may improve engraftment after transplant for HLH. British Journal of Haematology. 188(6). e84–e87. 10 indexed citations
8.
Abraham, Allistair, Michael D. Keller, Carolina Colli Cruz, et al.. (2019). Safety and feasibility of virus-specific T cells derived from umbilical cord blood in cord blood transplant recipients. Blood Advances. 3(14). 2057–2068. 33 indexed citations
9.
Naik, Swati, Olive S. Eckstein, Ghadir Sasa, et al.. (2019). Incorporation of Thiotepa in a Reduced Intensity Conditioning Regimen Leads to Improved Engraftment after Stem Cell Transplant for Patients with Hemophagocytic Lymphohistiocytosis. Blood. 134(Supplement_1). 3273–3273. 1 indexed citations
10.
Naik, Swati, Ghadir Sasa, Bilal Omer, et al.. (2019). Myeloablative Conditioning with Alemtuzumab in Matched Related Donor Hematopoietic Cell Transplant for Sickle Cell Disease Prevents Graft-Versus-Host Disease without Compromising Engraftment. Biology of Blood and Marrow Transplantation. 25(3). S39–S39. 1 indexed citations
11.
Thakar, Monica S., Larisa Broglie, Brent R. Logan, et al.. (2018). The Hematopoietic Cell Transplant Comorbidity Index predicts survival after allogeneic transplant for nonmalignant diseases. Blood. 133(7). 754–762. 35 indexed citations
12.
Tzannou, Ifigeneia, Kathryn Leung, Caridad Martinez, et al.. (2016). Safety and Preliminary Efficacy of "Ready to Administer" Cytomegalovirus (CMV)-Specific T Cells for the Treatment of Patients with Refractory CMV Infection. Blood. 128(22). 388–388. 1 indexed citations
13.
Zhou, Xiaoou, Gianpietro Dotti, Robert A. Krance, et al.. (2015). Inducible caspase-9 suicide gene controls adverse effects from alloreplete T cells after haploidentical stem cell transplantation. Blood. 125(26). 4103–4113. 169 indexed citations
14.
Zhou, Xiaoou, Antonio Di Stasi, Siok‐Keen Tey, et al.. (2014). Long-term outcome after haploidentical stem cell transplant and infusion of T cells expressing the inducible caspase 9 safety transgene. Blood. 123(25). 3895–3905. 139 indexed citations
15.
Παπαδοπούλου, Αναστασία, Usha L. Katari, Ulrike Gerdemann, et al.. (2013). Safety and Clinical Efficacy Of Rapidly-Generated Virus-Specific T Cells With Activity Against Adv, EBV, CMV, HHV6 and BK Virus Administered After Allogeneic Hematopoietic Stem Cell Transplant. Blood. 122(21). 148–148. 3 indexed citations
16.
Marino, Roberta, Satoru Otsuru, Ted J. Hofmann, et al.. (2013). Delayed Marrow Infusion in Mice Enhances Hematopoietic and Osteopoietic Engraftment by Facilitating Transient Expansion of the Osteoblastic Niche. Biology of Blood and Marrow Transplantation. 19(11). 1566–1573. 3 indexed citations
17.
El‐Bietar, Javier, Caridad Martinez, Catherine M. Bollard, et al.. (2013). Evaluating Donor Lymphocyte Infusions (DLI) for the Treatment of Falling Chimerism, Minimal Residual Disease and Relapse After Pediatric Hematopoietic Stem Cell Transplantation (HSCT). Biology of Blood and Marrow Transplantation. 19(2). S195–S196.
18.
Stasi, Antonio Di, Siok‐Keen Tey, Gianpietro Dotti, et al.. (2011). Inducible Apoptosis as a Safety Switch for Adoptive Cell Therapy. New England Journal of Medicine. 365(18). 1673–1683. 1159 indexed citations breakdown →
19.
Lin, Yu‐Feng, David R. Lairson, Wenyaw Chan, et al.. (2010). Children with acute leukemia: A comparison of outcomes from allogeneic blood stem cell and bone marrow transplantation. Pediatric Blood & Cancer. 56(1). 143–151. 5 indexed citations
20.
Martinez, Caridad, et al.. (2002). [Iron supplementation in a child with severe burns].. PubMed. 56(6). 579–81. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026